polski
pl
English
en
Dom
Informacje dotyczące COVID-19
Usługi
Kontakt
O
Ostrzeżenia FDA dotyczące leków
Sklep
Sklep
Ostrzeżenia FDA dotyczące leków
OSTRZEŻENIA FDA DOTYCZĄCE LEKÓW
JUN
06
Church & Dwight Issues Voluntary Nationwide Recall of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs Due to Microbial Contamination
By:
on
JUN
06
Audience: Consumer June 06, 2025 -- Church & Dwight Co., Inc. is voluntarily recalling all lots within expiry of Zicam® Cold Remedy Nasal Swabs, Zicam® Nasal AllClear Swabs, and Orajel™ Baby Teething Swabs to the consumer level...
Przeczytaj więcej >>
JUN
02
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Sulfamethoxazole / Trimethoprim Tablets, USP, 400 mg/80 mg Only, Due to Microbial Contamination
By:
on
JUN
02
Audience: Consumer, Pharmacy, Health Care Professional June 02, 2025 -- Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on...
Przeczytaj więcej >>
MAY
23
Drug Safety Communication - FDA Warns About Risk of Severe Itching After Discontinuation of Long-Term Use of Allergy Medicines Cetirizine or Levocetirizine
By:
on
MAY
23
Audience: Consumer, Patient, Health Care Professional, Pharmacy, Dermatology May 23, 2025 -- The FDA is warning that patients stopping the oral allergy medicines cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use may experience rare...
Przeczytaj więcej >>
MAY
21
Umary USA Issues Voluntary Nationwide Recall of Unavy Ácido Hialurónico Caplets and Umovy Ácido Hialurónico Caplets Due to the Presence of Undeclared Drug Ingredients
By:
on
MAY
21
Audience: Consumer May 21 2025, Nogales, AZ, Umary USA is voluntarily recalling all lots of Unavy Ácido Hialurónico (30 caplets/850 mg) and Umovy Ácido Hialurónico (30 caplets/850 mg), to the consumer level. FDA...
Przeczytaj więcej >>
MAY
16
FDA Drug Safety Communication: FDA Requires Warning About the Risk of Pruritus After Stopping Long-Term Use of Cetirizine or Levocetirizine
By:
on
MAY
16
Audience: Health Care Professionals, Consumers May 16, 2025 -- FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names). Can occur...
Przeczytaj więcej >>
MAY
09
FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated
By:
on
MAY
09
Audience: Health Care Providers, Consumers May 9, 2025 - The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are recommending a pause in the use of Ixchiq (Chikungunya Vaccine, Live) in individuals 60...
Przeczytaj więcej >>
MAY
06
Voluntary Nationwide Recall: Endurance Boost With Horny Goat Weed Capsules Due To Presence of Undeclared Propoxyphenylsildenafil and Sildenafil
By:
on
MAY
06
Audience: Consumer May 6, 2025 -- EnShiShiXiangNiShangMaoYouXianGongSi is voluntarily recalling one lot of Endurance Boost With Horny Goat Weed (20 Count) capsules to the consumer level. During the regular sampling, the product has been found to be...
Przeczytaj więcej >>
APR
25
Health Fixer Issues Voluntary Nationwide Recall of Male Ultra, Malextra, Electro Buzz, Ultra Armor and Male Ultra Pro
By:
on
APR
25
Audience: Consumer April 25, 2025 – Tempe, AZ, HEALTH FIXER is voluntarily recalling all lots of dietary supplements by the name of Male Ultra, Malextra, Electro Buzz, Ultra Armor and Male Ultra Pro- blister packs of 10 capsules per box/carton...
Przeczytaj więcej >>
APR
22
FDA Alerts Health Care Providers, Compounders and Consumers of Potential Risks Associated with Compounded Topical Finasteride Products
By:
on
APR
22
Audience: Health Care Providers, Compounders, Consumers April 22, 2025 -- FDA has become aware of reports of adverse events involving compounded topical finasteride products potentially putting consumers at risk. The agency is aware of some...
Przeczytaj więcej >>
APR
18
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter
By:
on
APR
18
Audience: Consumer, Health Professional, Pharmacy April 18, 2025 -- Bridgewater, NJ, Amneal Pharmaceutical LLC, is recalling two lots of Ropivacaine Hydrochloride Injection, USP, 500mg/100mL, Infusion bags to the hospital/user level as the products...
Przeczytaj więcej >>
Więcej wpisów
Wizyty na szczepionkę / testy na COVID-19
Aby zapewnić dostępną opiekę i lepsze zdrowie WSZYSTKIM członkom naszej społeczności.
USŁUGI
Leki na receptę
Bez recepty
Szczepienia
Darmowa dostawa do domu
MTM
CRM
Godziny pracy
Pon - Pt
10:00 am
-
6:00 pm
Sobota
10:00 am
-
2:00 pm
Niedziela
Zamknięte
KONTAKT
(609) 323-7503
ewingpharmacy@gmail.com
1400 Parkway Ave, A2
Ewing, NJ 08628
Copyright 2021 Apteka Ewing
Zaprojektowane i stworzone przez FinerrTM
Share by: